Vesicor was founded in 2008 and focuses on the development of p53-based cancer therapeutics delivered through microvesicles. The transaction, which has been approved by the boards of both companies, ...

A New York Times investigation revealed that numerous missteps were made ahead of the Jan. 29 midair collision that killed 67 ...